Trial intelligence / Profile preview

Aspirin Dosing Regimens in T2DM and CAD

NCT01201785Phase 4Completed

Sponsor
University of Florida
Start
Jan 2009
Primary completion
Sep 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of aspirin in coronary artery disease (CAD), sponsored by University of Florida. Started Jan 2009; status: completed.

02

Drugs

aspirin
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01201785.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01201785.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call